Extrapulmonary Tuberculosis Infection in Mexican Patients With Idiopathic Inflammatory Myopathies

J Clin Rheumatol. 2015 Sep;21(6):331-2. doi: 10.1097/RHU.0000000000000288.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Immunosuppressive Agents* / adverse effects
  • Male
  • Medication Therapy Management
  • Mexico / epidemiology
  • Middle Aged
  • Myositis* / diagnosis
  • Myositis* / drug therapy
  • Myositis* / etiology
  • Prevalence
  • Retrospective Studies
  • Risk Adjustment
  • Risk Factors
  • Secondary Prevention
  • Tuberculosis, Central Nervous System* / complications
  • Tuberculosis, Central Nervous System* / drug therapy
  • Tuberculosis, Central Nervous System* / epidemiology
  • Tuberculosis, Cutaneous* / complications
  • Tuberculosis, Cutaneous* / drug therapy
  • Tuberculosis, Cutaneous* / epidemiology
  • Tuberculosis, Osteoarticular* / complications
  • Tuberculosis, Osteoarticular* / drug therapy
  • Tuberculosis, Osteoarticular* / epidemiology

Substances

  • Immunosuppressive Agents